Retraction: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation.

Bibliographic Details
Main Author:	PLOS ONE Editors
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC6650076?pdf=render

Retraction: Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation.
by: Guo-Ying Wang, et al.
Published: (2011-01-01)

Retraction: Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: The Ratio of Circulating Regulatory T Cells (Tregs)/Th17 Cells Is Associated with Acute Allograft Rejection in Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Artificial Liver Support System Combined with Liver Transplantation in the Treatment of Patients with Acute-on-Chronic Liver Failure.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3.
by: PLOS ONE Editors
Published: (2017-01-01)

Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer.
by: Xiaoli Liu, et al.
Published: (2017-01-01)

Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy.
by: Zhaoqing Du, et al.
Published: (2018-01-01)

Retraction: Symptom Experienced Three Years after Liver Transplantation under Immunosuppression in Adults.
by: PLOS ONE Editors
Published: (2019-01-01)

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.
by: Wenzhe Fan, et al.
Published: (2015-01-01)

The Perioperatively Altered Neutrophil-to-Lymphocyte Ratio Associates with Impaired DNA Damage Response in Liver Transplantation Recipients with Hepatocellular Carcinoma
by: Kuang-Den Chen, et al.
Published: (2021-01-01)

Retraction: Circulating FoxP3+ regulatory T and interleukin17-producing Th17 cells actively influence HBV clearance in de novo Hepatitis B virus infected patients after orthotopic liver transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver Failure.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: De novo Cancers Following Liver Transplantation: A Single Center Experience in China.
by: PLOS ONE Editors
Published: (2019-01-01)

Correction: Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy.
by: Zhaoqing Du, et al.
Published: (2019-01-01)

Retraction: Silencing Alpha-Fetoprotein Inhibits VEGF and MMP-2/9 Production in Human Hepatocellular Carcinoma Cell.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: Novel Single Nucleotide Polymorphisms in Interleukin 6 Affect Tacrolimus Metabolism in Liver Transplant Patients.
by: PLOS ONE Editors
Published: (2019-01-01)

Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis
by: Xiao-Dong Sun, et al.
Published: (2016-01-01)

Retraction: Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Genetic Polymorphism of Interferon Regulatory Factor 5 (IRF5) Correlates with Allograft Acute Rejection of Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Preoperative neutrophil-to-lymphocyte ratio is a predictor of recurrence following thermal ablation for recurrent hepatocellular carcinoma: a retrospective analysis.
by: Xin Li, et al.
Published: (2014-01-01)

Retraction: New Diagnosis and Therapy Model for Ischemic-Type Biliary Lesions following Liver Transplantation-A Retrospective Cohort Study.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Intraoperative Cryoprecipitate Transfusion and Its Association with the Incidence of Biliary Complications after Liver Transplantation-A Retrospective Cohort Study.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Hyperthermia-Induced NDRG2 Upregulation Inhibits the Invasion of Human Hepatocellular Carcinoma via Suppressing ERK1/2 Signaling Pathway.
by: PLOS ONE Editors
Published: (2020-01-01)

Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation.
by: Chuan Li, et al.
Published: (2013-01-01)

Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.
by: Jie Hu, et al.
Published: (2011-01-01)

Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma.
by: Li-Ming Wu, et al.
Published: (2010-12-01)

Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma
by: Jian Hu, et al.
Published: (2018-12-01)

Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
by: Najjar M, et al.
Published: (2018-01-01)

Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma
by: T. Kabir, et al.
Published: (2019-01-01)

Retraction: Histones-Mediated Lymphocyte Apoptosis during Sepsis Is Dependent on p38 Phosphorylation and Mitochondrial Permeability Transition.
by: PLOS ONE Editors
Published: (2020-01-01)

Value of Model for End-Stage Liver Disease score combined with neutrophil-lymphocyte ratio in predicting the short-term prognosis of patients with HBV-related acute-on-chronic liver failure
by: ZHANG Li, et al.
Published: (2018-03-01)

Neutrophil-lymphocyte ratio: a novel predictor of clinical outcome of patients with hepatocellular carcinoma
by: WANG Xianbo, et al.
Published: (2016-04-01)

Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
by: Oh Byong Sun, et al.
Published: (2013-02-01)

Retraction: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation.

Similar Items

Similar Items